The estimated Net Worth of Yaky Yanay is at least $5.19 Million dollars as of 8 April 2019. Mr. Yanay owns over 71,429 units of Pluri Inc stock worth over $4,253,045 and over the last 17 years he sold PSTI stock worth over $586,429. In addition, he makes $350,377 as President, Chief Executive Officer, and Director at Pluri Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Yanay PSTI stock SEC Form 4 insiders trading
Yaky has made over 15 trades of the Pluri Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he bought 71,429 units of PSTI stock worth $50,000 on 8 April 2019.
The largest trade he's ever made was buying 71,429 units of Pluri Inc stock on 8 April 2019 worth over $50,000. On average, Yaky trades about 8,343 units every 84 days since 2007. As of 8 April 2019 he still owns at least 4,253,045 units of Pluri Inc stock.
You can see the complete history of Mr. Yanay stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Yaky Yanay biography
Yaky Yanay serves as President, Chief Executive Officer, Director of the Company. Mr. Yanay served as the Co-Chairman of Israel Advanced Technology Industries (IATI), the largest umbrella organization representing Israel’s high tech and life science industries and since August 2012 has continually served as a Director of IATI, representing Israel’s life sciences industry. Prior to joining the Company, Mr. Yanay founded and served as Chairman of “The Israeli Life Science Forum” and also served as the CFO of Elbit Vision Systems Ltd., a public company. In addition, from July 2010 to April 2018, he served on the Board of Directors of Elbit Vision Systems Ltd. Prior to these positions, Mr. Yanay served as manager of audit groups of the technology sector at Ernst & Young Israel. Mr. Yanay holds a bachelor’s degree with honors in business administration and accounting from the College of Management Academic Studies of Rishon LeZion and is a Certified Public Accountant in Israel.
What is the salary of Yaky Yanay?
As the President, Chief Executive Officer, and Director of Pluri Inc, the total compensation of Yaky Yanay at Pluri Inc is $350,377. There are 2 executives at Pluri Inc getting paid more, with Yaacov Yanay having the highest compensation of $612,604.
How old is Yaky Yanay?
Yaky Yanay is 48, he's been the President, Chief Executive Officer, and Director of Pluri Inc since 2019. There are 5 older and 2 younger executives at Pluri Inc. The oldest executive at Pluri Inc is Mark Germain, 69, who is the Independent Director.
What's Yaky Yanay's mailing address?
Yaky's mailing address filed with the SEC is MATAM PARK, BUILDING #5, , HAIFA, L3, 3508409.
Insiders trading at Pluri Inc
Over the last 17 years, insiders at Pluri Inc have traded over $7,081,854 worth of Pluri Inc stock and bought 2,345,914 units worth $14,327,834 . The most active insiders traders include Wolf Capital Limited Part..., Zami Aberman, and Israel Ben Yoram. On average, Pluri Inc executives and independent directors trade stock every 64 days with the average trade being worth of $54,123. The most recent stock trade was executed by Zami Aberman on 10 February 2022, trading 80,616 units of PSTI stock currently worth $145,109.
What does Pluri Inc do?
Pluristem Therapeutics Inc. is a leading regenerative medicine company developing novel placenta-based cell therapy product candidates. The Company has reported robust clinical trial data in multiple indications for its patented PLX cell product candidates and is currently conducting late-stage clinical trials in several indications. PLX cell product candidates are believed to release a range of therapeutic proteins in response to inflammation, muscle trauma, hematological disorders and radiation damage. The cells are grown using the Company's proprietary three-dimensional expansion technology and can be administered to patients off- the-shelf, without tissue matching. Pluristem has a strong intellectual property position; a
What does Pluri Inc's logo look like?
Complete history of Mr. Yanay stock trades at Pluri Inc
Pluri Inc executives and stock owners
Pluri Inc executives and other stock owners filed with the SEC include:
-
Yaacov Yanay,
Pres, CEO & Director -
Zalman Aberman,
Executive Chairman of the Board -
Yaky Yanay,
President, Chief Executive Officer, Director -
Chen Franco-Yehuda,
Chief Financial Officer, Treasurer, Secretary -
Dana Rubin,
Director of Investor Relations -
Moria Kwiat,
Independent Director -
Mark Germain,
Independent Director -
Isaac Braun,
Independent Director -
Doron Shorrer,
Lead Independent Director -
Dr. Nitsan Halevy M.D.,
Chief Medical Officer -
Efrat Livne-Hadass,
VP of HR -
Lior Raviv,
Chief Technology Officer -
Israel Ben Yoram,
Director -
Nachum Rosman,
Director -
Hava Meretzki,
Director -
Erez Egozi,
Chief Financial Officer -
Shai Pines,
Director -
Boaz Gur Lavie,
CFO -
Wolf Capital Limited Part...,
10% owner -
Maital Shemesh Rasmussen,
Director -
Rami Avraham Levi,
Director -
Pinhas Doron Birger,
Director -
Varda Shalev,
Director -
Zami Aberman,
Director